Lecanemab may slow cognitive decline in early Alzheimer’s disease
1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared...
Read MoreJan 11, 2023
1. Lecanemab was associated with reduced amyloid markers in early Alzheimer’s disease as compared...
Read MoreJan 10, 2023
1. Patients with chronic kidney disease (CKD) who used Decision-Aid for Renal Therapy (DART)...
Read MoreJan 10, 2023
1. For military personnel and veterans with PTSD, intensive outpatient prolonged exposure (IOP-PE)...
Read MoreJan 9, 2023
1. In patients with KRAS p.G12C mutated pancreatic cancer, 21% had a partial response, and 0% had...
Read MoreJan 9, 2023
1. Weekly dupilumab resulted in a significantly increased rate of histologic remission as compared...
Read MoreJan 8, 2023
1. High paternal rates of distress seen in fathers exposed to poor fetal, neonatal and maternal...
Read MoreJan 6, 2023
1. In this scoping review, Christian Orthodox Church (COC) fasters had healthier blood lipid...
Read MoreJan 4, 2023
1. Patients with hypertension who received chlorthalidone did not have a lower occurrence of...
Read MoreJan 3, 2023
1. A 24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) resulted in...
Read MoreJan 3, 2023
1. In this systematic review and meta-analysis, among the ten risk prediction scores analyzed,...
Read MoreDec 31, 2022
1. In patients with Bipolar Disorder Type 1, a smartphone-based self-management intervention...
Read MoreDec 28, 2022
1. In this randomized controlled trial, community-based diet and exercise education led to...
Read MoreDec 28, 2022
1. In a pre-birth prospective cohort study, early childhood smoke exposure, but not prenatal...
Read MoreDec 28, 2022
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD)...
Read MoreDec 28, 2022
1. In adolescents with obesity, semaglutide plus lifestyle intervention resulted in a significant...
Read MoreDec 28, 2022
1. In patients with diabetes mellitus who are on therapy with clopidogrel following percutaneous...
Read MoreDec 28, 2022
1. Topical gene therapy beremagene geperpavec (B-VEC) was superior to placebo in achieving...
Read MoreDec 28, 2022
1. Risk of hospital admission was lower in the ferric derisomaltose group versus usual care. 2....
Read MoreDec 28, 2022
1. In patients with chronic limb-threatening ischemia, major adverse limb events and mortality...
Read MoreDec 28, 2022
1. Incidence of total adverse events and specific adverse events were similar between the...
Read More